Wilkie GM - Search Results

1

Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases.

Wilkie GM, Taylor C, Jones MM, Burns DM, Turner M, Kilpatrick D, Amlot PL, Crawford DH, Haque T. Wilkie GM, et al. J Immunother. 2004 Jul-Aug;27(4):309-16. doi: 10.1097/00002371-200407000-00007. J Immunother. 2004. PMID: 15235392

2

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells.

Haque T, Wilkie GM, Taylor C, Amlot PL, Murad P, Iley A, Dombagoda D, Britton KM, Swerdlow AJ, Crawford DH. Haque T, et al. Among authors: wilkie gm. Lancet. 2002 Aug 10;360(9331):436-42. doi: 10.1016/S0140-6736(02)09672-1. Lancet. 2002. PMID: 12241714 Clinical Trial.

3

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

Haque T, Wilkie GM, Jones MM, Higgins CD, Urquhart G, Wingate P, Burns D, McAulay K, Turner M, Bellamy C, Amlot PL, Kelly D, MacGilchrist A, Gandhi MK, Swerdlow AJ, Crawford DH. Haque T, et al. Among authors: wilkie gm. Blood. 2007 Aug 15;110(4):1123-31. doi: 10.1182/blood-2006-12-063008. Epub 2007 Apr 27. Blood. 2007. PMID: 17468341 Free article. Clinical Trial.

4

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells.

Haque T, Taylor C, Wilkie GM, Murad P, Amlot PL, Beath S, McKiernan PJ, Crawford DH. Haque T, et al. Among authors: wilkie gm. Transplantation. 2001 Oct 27;72(8):1399-402. doi: 10.1097/00007890-200110270-00012. Transplantation. 2001. PMID: 11685111

5

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.

Vickers MA, Wilkie GM, Robinson N, Rivera N, Haque T, Crawford DH, Barry J, Fraser N, Turner DM, Robertson V, Dyer P, Flanagan P, Newlands HR, Campbell J, Turner ML. Vickers MA, et al. Among authors: wilkie gm. Br J Haematol. 2014 Nov;167(3):402-10. doi: 10.1111/bjh.13051. Epub 2014 Jul 26. Br J Haematol. 2014. PMID: 25066775 Free PMC article.

6

Treatment of Epstein-Barr-virus-associated primary CNS B cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation.

Wynn RF, Arkwright PD, Haque T, Gharib MI, Wilkie G, Morton-Jones M, Crawford DH. Wynn RF, et al. Lancet Oncol. 2005 May;6(5):344-6. doi: 10.1016/S1470-2045(05)70171-6. Lancet Oncol. 2005. PMID: 15863383 No abstract available.

7

Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease.

Kazi S, Mathur A, Wilkie G, Cheal K, Battle R, McGowan N, Fraser N, Hargreaves E, Turner D, Campbell JDM, Turner M, Vickers MA. Kazi S, et al. Haematologica. 2019 Aug;104(8):e356-e359. doi: 10.3324/haematol.2018.207548. Epub 2019 Feb 21. Haematologica. 2019. PMID: 30792197 Free PMC article. No abstract available.

8

Cytometric analysis of T cell phenotype using cytokine profiling for improved manufacturing of an EBV-specific T cell therapy.

Cooper RS, Kowalczuk A, Wilkie G, Vickers MA, Turner ML, Campbell JDM, Fraser AR. Cooper RS, et al. Clin Exp Immunol. 2021 Oct;206(1):68-81. doi: 10.1111/cei.13640. Epub 2021 Jul 14. Clin Exp Immunol. 2021. PMID: 34146397 Free PMC article.

9

Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders.

Gandhi MK, Wilkie GM, Dua U, Mollee PN, Grimmett K, Williams T, Whitaker N, Gill D, Crawford DH. Gandhi MK, et al. Among authors: wilkie gm. Am J Transplant. 2007 May;7(5):1293-9. doi: 10.1111/j.1600-6143.2007.01796.x. Epub 2007 Apr 8. Am J Transplant. 2007. PMID: 17425621 Free article.

10

Interferon gamma (IFN-gamma) polymorphism in posttransplantation lymphoproliferative disease.

Thomas RV, McAulay K, Higgins C, Wilkie G, Crawford DH. Thomas RV, et al. Blood. 2005 Aug 15;106(4):1502-3; author reply 1503. doi: 10.1182/blood-2005-03-1279. Blood. 2005. PMID: 16079437 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters